Bexion Loogo

Making Significant Progress.

Bexion at a glance data

Our Leadership

Bexion’s leadership team has extensive experience across pharmaceutical operations, discovery, research and development, manufacturing, clinical, regulatory, and commercialization

Ray Takigiku, Ph.D.
President and CEO

Jim Beach

Christy Rothwell, Ph.D., J.D.
Intellectual Property

Michael Gazda, Ph.D.
Chemistry, Manufacturing, and Controls

Margaret van Gilse, M.B.A.
Business Development

Richard C. Curry III, MD
Medical Affairs Consultant

Richard J. Schwen, PhD, DABT, RAC
Regulatory Consultant

About Bexion
High Market Potential
Why Invest?
The Promise of BXQ-350